1.Influence of AKT on survival and apoptosis of gastric adenocarcinoma cells.
Yong LIU ; Ming-zhi LU ; Si-si FAN ; Sheng YUAN
Chinese Journal of Pathology 2009;38(5):340-341
Adenocarcinoma
;
pathology
;
Apoptosis
;
drug effects
;
Cell Line, Tumor
;
Cell Survival
;
drug effects
;
Dose-Response Relationship, Drug
;
Humans
;
Nucleosides
;
administration & dosage
;
pharmacology
;
Proto-Oncogene Proteins c-akt
;
antagonists & inhibitors
;
Pyridazines
;
administration & dosage
;
pharmacology
;
Stomach Neoplasms
;
pathology
2.Exploration and practice of bilingual teaching in pediatrics of the undergraduates
Bao-Qiang YUAN ; Yuan-Yuan DAI ; Qiu-Ping FAN ; Hua CHENG ; Jun WANG ; Si-Guang LU ;
Chinese Journal of Medical Education Research 2006;0(07):-
To further explore the result of bilingual teaching in pediatrics,we randomly chose 200 undergraduates of 4 class and released students'questionnaires about bilingual teaching with teaching content before and after class to assess students'understanding of bilingual teaching and analysed appraisal result.We found no significant difference of student score between students accepting bilingual teaching and not accepting the bilingual teaching,but there was difference for English tests and expression level.So we think that students can fully accept the bilingual teaching of pediatrics under the premise with selecting appropriate teaching methods and means.
3.Progress on application of PD⁃1/PD⁃L1 monoclonal antibodies in oncotherapy
WANG Si⁃yuan ; LU Hui ; YANG Chun
Chinese Journal of Biologicals 2023;36(1):105-111+118
Abstract:Programmed death receptor⁃ 1(PD⁃1)belongs to the family of immunoglobulin B7⁃CD28,which plays an
important role in regulating immune response in human body. Since the first PD⁃1/PD⁃ligand 1(PD⁃L1)monoclonal
antibody was approved for marketing in China in 2018,the value of PD⁃1/PD⁃L1 immunotherapy in oncotherapy has
attracted wide attention. Based on the introduction of the action mechanism of PD⁃1/PD⁃L1 mAbs,this paper reviews the
application progress of 8 on ⁃ market PD ⁃ 1/PD ⁃ L1 mAbs in China in oncotherapy from the perspectives of approved
indications,clinical trials,usage and dosage,and adverse reactions,in order to provide reference for the rational appli⁃
cation of PD⁃1/PD⁃L1 monoclonal antibodies in clinic.
4.Relationship between sorafenib's side effects and efficacy in treatment of advanced renal cell carcinoma patients
Zhihong CHI ; Xinan SHENG ; Hongyun LIAN ; Lu SI ; Chuanliang CUI ; Xiangqing YUAN ; Jun GUO
Chinese Journal of Urology 2009;30(1):28-31
Objective To identify the relationship between sorafenib's efficacy and its side effects in treatment of advanced renal cell carcinoma patients. Methods Fifty-one patients having measurable diseases were diagnosed with advanced renal cell carcinoma. Of whom, 26 patients were in stage T1Nx,0,1M1, 12 patients in stage T2Nx,0 M1, 8 patients in stage T3NxM1, 5 patients in stage T4NxM1. These 46 patients of T1 -T3 had their primary diseases removed, but the 5 T~ patients didn"t have their primary diseases removed. These 51 patients received oral sorafenib 400 mg Bid continual-ly and they had CT scan every two months to evaluate the progression. The dosage of sorafenib wasmodified according to efficacy and toxicity. Two patients changed the dosage to 200 mg Bid due to se-vere side effects. Sixteen patients increased the dosage to 600 mg Bid or 800 mg Bid. The response ofSorafenib and toxicities as well as their severity were recorded. The toxicity severity was graded ac-cording to National Cancer Institute Common Toxicity Criteria version 3.0. The efficacy was deter-mined by RECIST criteria. The efficacy and progression free survival (PFS) were recorded. The sta-tistics analysis was conducted between sorafenib's side effects and efficacy as well as their severity by multi-faetor Logistic regression. Results The rates of adverse events in the patients receiving oral sorafenib were hand-foot skin reaetion 68. 6% (35/51), diarrhea 39. 2% (20/51), rash 25. 5% (13/ 51), mucositis 23.5% (12/51), hypertension 17.6% (9/51), and myelosuppression 13. 7%(7/51). The response rate in the patients who had toxicity of grade 3-4 was 33.3%(12/36), and that in the patients who had slight toxicity was 12.0%(3/25). The rate of hand-foot skin reaction was higher than that of diarrhea, rash, mucositis, hypertension and bone marrow suppression (P<0.01). Sor-afenib's efficacy was eorrelated to rash and mueositis (P=0.048, 0.045 respectively). More grade 3 4 side effects occurred in the patients who would have better response to sorafenib (P=0.008). The median PFS was 15.0 months and PFS was not related to the toxicity and its severity. Conclusions It may help to predict the response for sorafenib's side effects and efficacy in the treatment of the patients with advaneed renal cell earcinoma.
5.Predictive factors of sorafenib in the treatment of metastatic renal cell carcinoma
Xinan SHENG ; Zhihong CHI ; Hongyun LIAN ; Xiangqing YUAN ; Lu SI ; Chuanliang CUI ; Jun GUO
Chinese Journal of Urology 2009;30(1):25-27
Objective To analyze the effect and related factors of sorafenib in the treatment of metastatic renal cell carcinoma(MRCC), and identify the potential predictive factors of sorafenib re-sponse. Methods The data of 51 MRCC patients who received sorafenib therapy, with or without combination with interferon or chemotherapy were retrospectively reviewed. After two cycles of treat-ment, patients were evaluated for progression or response. Pearson Chi-square test and Logistic re-gression test were performed respectively as univariate and multivariate analyses of sorafenib response. Results The overall objective response rate was 29.4%(95% confidence interval 16.9% to 41.9%, with 1(2.0%) complete response and 14(27.4%) partial responses. Twenty-nine(56.9%) had stable disease, and 7 (13.7%) had progression disease (PD). Significant independent predictive factors asso-ciated with good response in multivariate analysis were lung metastasis only(P=0.021, HR=5.127). Conclusions Sorafenib is effective in MRCC patients. Lung metastasis only is predictive factor in mul-tivariate analysis for sorafenib response.
6.Study on quantitative methods of cleistocalycis operculati cortex.
Li-Si CHEN ; Jia-Ju OU ; Shu-Yuan LI ; Song-Gui LU
China Journal of Chinese Materia Medica 2014;39(16):3128-3130
Cleistocalycis Operculati Cortex is the dry bark of Cleistocalyx operculatus. It is the raw material of Compound Hibiscuse which is external sterilization antipruritic drugs. The quality standard of Cleistocalycis Operculati Cortex in Guangdong Province "standard for the traditional Chinese medicine" (second volumes) only contains TLC identification. It is unable to effectively monitor and control the quality of Cleistocalycis Operculati Cortex. A reversed-phase HPLC method was established for the determination of 3, 3'-O-dimethylellagic acid from Cleistocalycis Operculati Cortex and the content was calculated by external standard method for the first time. Under the selected chromatographic conditions, the target components between peaks to achieve effective separation. 3,3'-O- dimethylellagic acid standard solution at the concentration of 1.00 - 25.0 mg x L(-1) showed a good linear relationship. The standard curve was Y = 77.33X + 7.904, r = 0.999 5. The average recovery was 101.0%, RSD was 1.3%. The HPLC method for the determination of 3,3'-O-dimethylellagic acid in Cleistocalycis Operculati Cortex is accurate and reliable. It can provide a strong technical support for monitoring the quality of Cleistocalycis Operculati Cortex.
Chromatography, High Pressure Liquid
;
methods
;
Chromatography, Reverse-Phase
;
methods
;
Drugs, Chinese Herbal
;
analysis
;
Plant Bark
;
chemistry
;
Syzygium
;
chemistry
7.Rules for acupoint selection in treatment of perimenopausal syndrome based on data mining technology.
Ling-yun LU ; Si-yuan ZHOU ; Ting LIU ; Er-qi QIN ; Yu-lan REN ; Ying LI
Chinese Acupuncture & Moxibustion 2014;34(10):1017-1022
OBJECTIVETo analyze the rules for acupoint selection of acupuncture and moxibustion in domestic clinical treatment of perimenopausal syndrome based on data mining technology in modern times.
METHODSThe relevant literature were retrieved from Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI) and Wanfang database on this disease treated with clinical acupuncture and moxibustion in China from 1978 to 2013. The database of acupuncture-moxibustion prescription was set up. The relevant regulations of data mining technology were used to analyze the rules for acupoint selection.
RESULTSTotally, 211 papers, 254 acupuncture-moxibustion prescriptions and 130 acupoints were included. The total frequency of acupoints application was 2193 times, with 14 meridians involved. The utilization of the acupoints in the lower limbs and on the back were 33.0% (723/2193) and 23.8% (521/2193) and those of yin and yang meridians were 51.8% (1136/2193) and 44.0% (965/2193), respectively. The utilization of the specific acupoints accounted for 88.7% (1946/2193).
CONCLUSIONIn clinical treatment of perimenopausal syndrome with acupuncture and moxibustion in modern times, the acupoint selection from involved meridians is the basis, associated with multiple methods of acupoint combination; yin and yang meridians are equally important and the specific acupoints are considered particularly critical in application.
Acupuncture Points ; Acupuncture Therapy ; China ; Clinical Trials as Topic ; Female ; Humans ; Perimenopause ; physiology
8.Knowledge discovery based on artificial neural network data mining in population pharmacokinetics
Hai-Yan WANG ; Lu-Yi ZHOU ; Si-Bo LU ; Li YANG ; Jin-Yuan HUANG ; Cheng-Yu LU
The Chinese Journal of Clinical Pharmacology 2018;34(20):2449-2451
Objective Artificial neural networks ( ANN) is an integral part of artificial intelligence.In this paper, the architecture of artificial neural networks in population pharmacokinetics is discussed and summa -rized according to the data mining techniques of medical information . Methods The data samples of population pharmacokinetics in network databases are collected by data mining , and a large sample population pharmacokinetics ( PPK) database is generated by simulation , and an artificial neural network PPK model based on SPSS system is established . Results The simulated large sample PPK data have the same statistical characteristics as those reported in the literature.The ANN model is sim-ple and the analysis accuracy is better. Conclusion ANN analysis model can be reconstructed by PKK data mining and simulation .
9.Clinical observation of main symptoms relief by Chinese Jing Liqueur in patients with Kidney Yang Deficiency Syndrome
Shi-Guang LU ; Jing LI ; Ya-Fang ZHANG ; Lei WANG ; Yue-Jun YANG ; Mo-Si CHEN ; Jiao SHI ; Yuan-Cai LIU
Chinese Traditional Patent Medicine 2018;40(3):562-570
AIM To investigate the efficacy and safety of Chinese Jing Liqueur (Curculiginis Rhizoma,Angelicae sinensis Radix,Cistanches Herba,etc.) in relieving main symptoms of patients with Kidney Yang Deficiency Syndrome.METHODS Within eight-week trial,one hundred and twenty patients randomly and equally assigned to control group and experimental group took 50 mL Chinese Jing Liqueur and 50 mL 10% diluted Chinese Jing Liqueur,respectively.The grading scale for Kidney Yang Deficiency Syndrome and change curve for body surface temperature after drinking were established on day 0,the 4th week day and the 8th week day.The blood samples were collected for blood hemorheologies detection as well.An array of measurements before and after drinking,the Kidney Yang Deficiency Syndrome scores,single symptom scores,body surface temperature and hemorheologies between the two groups were thus compared.RESULTS The experimental group displayed a significantly higher clinical cure rate (31.034%) than the control group (5.172%) (P =0.000),total effective rate (69.966%)than the control group (34.483%) (P =0.000).The experimental group didn't compromise its superiority to the control group if evaluated by improvement in chilly sensation and the cold limbs (35.593% to 6.667%,P =0.000);and by the fibrinogen level [(2.845 ± 0.724) g/L to (2.500 ± 0.395) g/L,P =0.004)].No significant difference in incidence of adverse reactions between the two groups was observed (P =0.619).Meanwhile,Chinese Jing Liqueur's power in improving the patients' fatigue and weakness of waist and knees,hyposexuality,listlessness,nocturia and lower extremity edema was noticed as well.CONCLUSION For patients with Kidney Yang Deficiency Syndrome,Chinese Jing Liqueur proves its efficacy in improving their main symptoms through enhancing the basic skin temperature and prolonging the duration of skin temperature rise.
10.Evaluation of inhibitory effect of tumor vaccine in colon carcinoma model mice
Lu HAN ; LIANG Zhao yuan ; SHI Si wei ; YANG Li qun ; DENG Xiong wei ; SHENG Wang
Chinese Journal of Biologicals 2023;36(1):11-15+20
Objective:
To evaluate the inhibitory effect of tumor vaccines in colon carcinoma model mice.
Methods:
Mouse bone marrow⁃derived dendritic cells(BMDCs)were stimulated by using CpG β⁃glucan nanoparticles(CNP)in vitro. The
BMDCs were divided into PBS group,NP group(without CpG nanoparticles),Lysate group(MC38 cell lysate)and CpG
group(CpG1826),which were determined for the expression of marker molecules on the surface by flow cytometry and for the
contents of interleukin⁃6(IL⁃6)and IL⁃12p40 in the culture supernatant by ELISA. The tumor lysate nano⁃vaccine was pre⁃
pared by mixing 50 mg/mL tumor lysate(MC38 cell lysate)with 200 mg/mL CNP in a volume ratio of 1∶1,with which
mice were subcutaneously immunized as Vaccine group. Vaccine group,PBS group,CNP group and Lysate group were im⁃
munized once a week,for three times in total. Mice were subcutaneously inoculated with MC38 cells,2 × 105 cells for each,
in the right lower limb 1 h after the last immunization,and measured for tumor volume once every three days to plot the
tumor growth curve. The ratios of CD3+ CD4+ T and CD3+ CD8+ T cells in the blood were analyzed by flow cytometry and the
levels of tumor necrosis factor⁃α(TNF⁃α)and interferon γ(IFNγ)in the blood and spleen of mice were determined by
ELISA.
Results:
CNP effectively increased the expression of CD11c+ CD80+,CD11c+ CD86+,CD11c+ MHC⁃Ⅱ+ and the secretion of IL⁃6 and IL⁃12p40 in BMDCs in vitro,which were significantly higher than those in other 4 groups(t = 4. 3 ~
46. 2,each P < 0. 05). Compared with that of the other three groups,the tumor volume of mice in Vaccine group decreased
significantly(t =2.6~3.4,eachP <0. 05);TherewasnosignificantdifferenceinCD3+ CD8+ TandCD3+ CD8+ Tcellratios(t =
0.5~ 1. 9,each P > 0. 05);The content of IFNγ in blood increased significantly(t = 3. 8 ~ 4. 6,P < 0. 05),while thatof
TNF⁃α showed no significant difference(t = 0. 4 ~ 2. 0,each P > 0. 05);However,the contents of IFN γ and TNF⁃α in
spleen increased significantly(t = 6. 3 ~ 13. 0,each P < 0. 001).
Conclusion
The prepared nano⁃vaccine of tumor lysate
improvedtheimmune level in mice and effectively inhibited the growth of colon carcinoma.